MCK vs OGEN · P/E 20, rev $403.43B vs rev $37.7K
McKesson Corporation (MCK) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the MCK and OGEN stock pages for the full models.
Not investment advice.